{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:44:13Z","timestamp":1790948653660,"version":"4.1.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100019652","name":"British University in Egypt","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100019652","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"DOI":"10.1007\/s13346-026-02193-8","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T16:23:11Z","timestamp":1786206191000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Brain-targeted intranasal aripiprazole via modified chitosan nanoparticles: controlled release, pharmacokinetics, and pharmacodynamics"],"prefix":"10.1007","author":[{"given":"Rabab M.","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud H.","family":"Teaima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"El-Nabarawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha M.","family":"Badawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,8]]},"reference":[{"key":"2193_CR1","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1007\/S00289-021-03598-W\/FIGURES\/10","volume":"79","author":"Annu","year":"2022","unstructured":"Annu, Baboota S, Ali, J. In vitro appraisals and ex vivo permeation prospect of chitosan nanoparticles designed for schizophrenia to intensify nasal delivery. Polym Bull. 2022;79:2263\u201385. https:\/\/doi.org\/10.1007\/S00289-021-03598-W\/FIGURES\/10.","journal-title":"Polym Bull"},{"key":"2193_CR2","doi-asserted-by":"crossref","unstructured":"Ferreira M, Duarte J, Veiga F, Pharmaceutics AP-S. undefined 2023, Nanosystems for Brain Targeting of Antipsychotic Drugs: An Update on the Most Promising Nanocarriers for Increased Bioavailability and Therapeutic Efficacy, Mdpi.Com (n.d.). https:\/\/www.mdpi.com\/1999-4923\/15\/2\/678 (accessed June 17, 2023).","DOI":"10.3390\/pharmaceutics15020678"},{"key":"2193_CR3","unstructured":"Sawant K, Pandey A, SP-MS and C E. undefined 2016, Aripiprazole loaded poly (caprolactone) nanoparticles: Optimization and in vivo pharmacokinetics, Elsevier (n.d.). https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0928493116303976 (accessed June 17, 2023)."},{"key":"2193_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/S11033-023-08241-7","author":"JA Malik","year":"2023","unstructured":"Malik JA, Yaseen Z, Thotapalli L, Ahmed S, Shaikh MF, Anwar S. Understanding translational research in schizophrenia: A novel insight into animal models. Mol Biol Rep. 2023. https:\/\/doi.org\/10.1007\/S11033-023-08241-7.","journal-title":"Mol Biol Rep"},{"key":"2193_CR5","doi-asserted-by":"publisher","unstructured":"Spina E, Barbieri M, Cicala G, de Pharmaceuticals J. undefined 2020, Clinically relevant interactions between atypical antipsychotics and anti-infective agents, Mdpi.Com (n.d.). https:\/\/doi.org\/10.3390\/ph13120439","DOI":"10.3390\/ph13120439"},{"key":"2193_CR6","unstructured":"Joseph E, Reddi S, Rinwa V., \u2026 G.B.-I.J. of, undefined 2018, DoE based Olanzapine loaded poly-caprolactone nanoparticles decreases extrapyramidal effects in rodent model, Elsevier (n.d.). https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0378517318300851 (accessed August 5, 2023)"},{"key":"2193_CR7","doi-asserted-by":"publisher","first-page":"105885","DOI":"10.1016\/J.JDDST.2024.105885","volume":"99","author":"RM Ibrahim","year":"2024","unstructured":"Ibrahim RM, Teaima M, El-Nabarawi M, Badawi NM. Intranasal delivery of chitosan-based nanoparticles as an innovative way for management of neurodegenerative disorders: A comprehensive review of advanced strategies for CNS targeting. J Drug Deliv Sci Technol. 2024;99:105885. https:\/\/doi.org\/10.1016\/J.JDDST.2024.105885.","journal-title":"J Drug Deliv Sci Technol"},{"key":"2193_CR8","doi-asserted-by":"publisher","unstructured":"Orzelska-G\u00f3rka J, Mikulska J., \u2026 A.W.-I.J. of, undefined 2022, New Atypical Antipsychotics in the Treatment of Schizophrenia and Depression, Mdpi.Com (2022). https:\/\/doi.org\/10.3390\/ijms231810624","DOI":"10.3390\/ijms231810624"},{"key":"2193_CR9","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/S10973-020-09549-3","volume":"141","author":"IM T\u0103nase","year":"2020","unstructured":"T\u0103nase IM, Sb\u00e2rcea L, Lede\u021bi A, Vlase G, Barvinschi P, V\u0103ru\u0163 RM, Dragomirescu A, Axente C, Lede\u021bi I. Physicochemical characterization and molecular modeling study of host\u2013guest systems of aripiprazole and functionalized cyclodextrins. J Therm Anal Calorim. 2020;141:1027\u201339. https:\/\/doi.org\/10.1007\/S10973-020-09549-3.","journal-title":"J Therm Anal Calorim"},{"key":"2193_CR11","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1080\/10837450.2021.1948571","volume":"26","author":"S Taymouri","year":"2021","unstructured":"Taymouri S, Shahnamnia S, Mesripour A, Varshosaz J. In vitro and in vivo evaluation of an ionic sensitive in situ gel containing nanotransfersomes for aripiprazole nasal delivery. Pharm Dev Technol. 2021;26:867\u201379. https:\/\/doi.org\/10.1080\/10837450.2021.1948571.","journal-title":"Pharm Dev Technol"},{"key":"2193_CR12","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1208\/S12249-017-0944-5","volume":"19","author":"Silki","year":"2018","unstructured":"Silki, Sinha VR. Enhancement of In Vivo Efficacy and Oral Bioavailability of Aripiprazole with Solid Lipid Nanoparticles. AAPS PharmSciTech. 2018;19:1264\u201373. https:\/\/doi.org\/10.1208\/S12249-017-0944-5.","journal-title":"AAPS PharmSciTech"},{"key":"2193_CR13","unstructured":"Islam S, Shehzad A, Ahmed M. Y.L.-Molecules undefined 2020, Intranasal delivery of nanoformulations: a potential way of treatment for neurological disorders, Mdpi.Com (n.d.). https:\/\/www.mdpi.com\/697016 (accessed June 19, 2023)."},{"key":"2193_CR14","unstructured":"Li Y, Wu H, Jiang X, Dong Y, Zheng J, G.-A.P.S. B J. undefined 2022, New idea to promote the clinical applications of stem cells or their extracellular vesicles in central nervous system disorders: Combining with intranasal, Elsevier (n.d.). https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2211383522001587 (accessed June 19, 2023)."},{"key":"2193_CR15","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/S40263-022-00930-4","volume":"36","author":"A Lofts","year":"2022","unstructured":"Lofts A, Abu-Hijleh F, Rigg N, Mishra RK, Hoare T. Using the intranasal route to administer drugs to treat neurological and psychiatric illnesses: rationale, successes, and future needs. CNS Drugs. 2022;36:739\u201370. https:\/\/doi.org\/10.1007\/S40263-022-00930-4.","journal-title":"CNS Drugs"},{"key":"2193_CR16","doi-asserted-by":"publisher","unstructured":"Aderibigbe B. TN-A. sciences, undefined 2019, Chitosan-based nanocarriers for nose to brain delivery, Mdpi.Com (2019). https:\/\/doi.org\/10.3390\/app9112219","DOI":"10.3390\/app9112219"},{"key":"2193_CR17","unstructured":"Y. Chen, Y. Huang, Y. Chen, Y. Ye, \u2026 K.L.-C.C., undefined 2015, Novel nanoparticles composed of chitosan and \u03b2-cyclodextrin derivatives as potential insoluble drug carrier, Elsevier (n.d.). https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1001841715002375 (accessed June 22, 2023)."},{"key":"2193_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2018.02.010","author":"V Trotta","year":"2018","unstructured":"Trotta V, Pavan B, Ferraro L, Beggiato S, Traini D, Gomes L, Reis D, Scalia S, Dalpiaz AA. Brain targeting of resveratrol by nasal administration of chitosan-coated lipid microparticles. Elsevier. 2018. https:\/\/doi.org\/10.1016\/j.ejpb.2018.02.010.","journal-title":"Elsevier"},{"key":"2193_CR19","doi-asserted-by":"publisher","unstructured":"Caprifico A, Foot P, Polycarpou E. G.C.- Pharmaceutics, undefined 2020, Overcoming the blood-brain barrier: Functionalised chitosan nanocarriers, Mdpi.Com (n.d.). https:\/\/doi.org\/10.3390\/pharmaceutics12111013","DOI":"10.3390\/pharmaceutics12111013"},{"key":"2193_CR20","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.msec.2016.04.089","volume":"66","author":"K Sawant","year":"2016","unstructured":"Sawant K, Pandey A, Patel S. Aripiprazole loaded poly(caprolactone) nanoparticles: Optimization and in vivo pharmacokinetics. Mater Sci Eng C. 2016;66:230\u201343. https:\/\/doi.org\/10.1016\/j.msec.2016.04.089.","journal-title":"Mater Sci Eng C"},{"key":"2193_CR21","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1080\/02652048.2017.1375038","volume":"34","author":"A Javia","year":"2017","unstructured":"Javia A, Thakkar H. Intranasal delivery of tapentadol hydrochloride\u2013loaded chitosan nanoparticles: formulation, characterisation and its in vivo evaluation. J Microencapsul. 2017;34:644\u201358. https:\/\/doi.org\/10.1080\/02652048.2017.1375038.","journal-title":"J Microencapsul"},{"key":"2193_CR22","doi-asserted-by":"publisher","unstructured":"Yanat M, Schro\u00ebn K. Preparation methods and applications of chitosan nanoparticles; with an outlook toward reinforcement of biodegradable packaging. React Funct Polym. 2021;161. https:\/\/doi.org\/10.1016\/J.REACTFUNCTPOLYM.2021.104849.","DOI":"10.1016\/J.REACTFUNCTPOLYM.2021.104849"},{"key":"2193_CR23","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.proche.2014.12.011","volume":"13","author":"D Mudhakir","year":"2014","unstructured":"Mudhakir D, Wibisono C, Rachmawati H. Encapsulation of Risperidone into Chitosan-based Nanocarrier via Ionic Binding Interaction. Procedia Chem. 2014;13:92\u2013100. https:\/\/doi.org\/10.1016\/j.proche.2014.12.011.","journal-title":"Procedia Chem"},{"key":"2193_CR24","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1080\/03639040701836545","volume":"34","author":"T Nahata","year":"2008","unstructured":"Nahata T, Saini TR. D-optimal designing and optimization of long acting microsphere-based injectable formulation of aripiprazole. Drug Dev Ind Pharm. 2008;34:668\u201375. https:\/\/doi.org\/10.1080\/03639040701836545.","journal-title":"Drug Dev Ind Pharm"},{"key":"2193_CR25","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/J.ACA.2008.02.046","volume":"612","author":"A Musenga","year":"2008","unstructured":"Musenga A, Saracino MA, Spinelli D, Rizzato E, Boncompagni G, Kenndler E, Raggi MA. Analysis of the recent antipsychotic aripiprazole in human plasma by capillary electrophoresis and high-performance liquid chromatography with diode array detection. Anal Chim Acta. 2008;612:204\u201311. https:\/\/doi.org\/10.1016\/J.ACA.2008.02.046.","journal-title":"Anal Chim Acta"},{"key":"2193_CR26","doi-asserted-by":"publisher","first-page":"100423","DOI":"10.1136\/GPSYCH-2020-100423","volume":"34","author":"P Jiang","year":"2021","unstructured":"Jiang P, Sun X, Ren J, Liu H, Lin Z, Liu J, Fang X, Zhang C. Effects of the combination of second-generation antipsychotics on serum concentrations of aripiprazole and dehydroaripiprazole in Chinese patients with schizophrenia. Gen Psychiatr. 2021;34:100423. https:\/\/doi.org\/10.1136\/GPSYCH-2020-100423.","journal-title":"Gen Psychiatr"},{"key":"2193_CR27","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/J.JCHROMB.2005.03.024","volume":"821","author":"Y Shimokawa","year":"2005","unstructured":"Shimokawa Y, Akiyama H, Kashiyama E, Koga T, Miyamoto G. High performance liquid chromatographic methods for the determination of aripiprazole with ultraviolet detection in rat plasma and brain: application to the pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci. 2005;821:8\u201314. https:\/\/doi.org\/10.1016\/J.JCHROMB.2005.03.024.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"2193_CR28","doi-asserted-by":"publisher","first-page":"733","DOI":"10.2147\/IJN.S345870","volume":"17","author":"NM Badawi","year":"2022","unstructured":"Badawi NM, Attia YM, El-Kersh DM, Hammam OA, Khalifa MKA. Investigating the impact of optimized trans-cinnamic acid-loaded PLGA nanoparticles on epithelial to mesenchymal transition in breast cancer. Int J Nanomed. 2022;17:733\u201350. https:\/\/doi.org\/10.2147\/IJN.S345870.","journal-title":"Int J Nanomed"},{"key":"2193_CR29","doi-asserted-by":"crossref","unstructured":"Shah B, Khunt D, Misra M. H.P.-I. journal of biological, undefined 2016, Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route*, Elsevier (n.d.).","DOI":"10.1016\/j.ijbiomac.2016.04.076"},{"key":"2193_CR30","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.1016\/j.xphs.2019.05.001","volume":"108","author":"I Jazuli","year":"2019","unstructured":"Jazuli I, Nabi AB, Moolakkadath T, Alam T, Baboota S, Ali J. Optimization of Nanostructured Lipid Carriers of Lurasidone Hydrochloride Using Box-Behnken Design for Brain Targeting: In Vitro and In Vivo Studies. J Pharm Sci. 2019;108:3082\u201390. https:\/\/doi.org\/10.1016\/j.xphs.2019.05.001.","journal-title":"J Pharm Sci"},{"key":"2193_CR31","doi-asserted-by":"publisher","first-page":"119038","DOI":"10.1016\/J.IJPHARM.2020.119038","volume":"577","author":"WK Delan","year":"2020","unstructured":"Delan WK, Zakaria M, Elsaadany B, ElMeshad AN, Mamdouh W, Fares AR. Formulation of simvastatin chitosan nanoparticles for controlled delivery in bone regeneration: Optimization using Box-Behnken design, stability and in vivo study. Int J Pharm. 2020;577:119038. https:\/\/doi.org\/10.1016\/J.IJPHARM.2020.119038.","journal-title":"Int J Pharm"},{"key":"2193_CR32","doi-asserted-by":"publisher","first-page":"119361","DOI":"10.1016\/J.IJPHARM.2020.119361","volume":"583","author":"V Piazzini","year":"2020","unstructured":"Piazzini V, Landucci E, Urru M, Chiarugi A, Pellegrini-Giampietro DE, Bilia AR, Bergonzi MC. Enhanced dissolution, permeation and oral bioavailability of aripiprazole mixed micelles: In vitro and in vivo evaluation. Int J Pharm. 2020;583:119361. https:\/\/doi.org\/10.1016\/J.IJPHARM.2020.119361.","journal-title":"Int J Pharm"},{"key":"2193_CR33","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/08982104.2019.1610435","volume":"30","author":"RA Khallaf","year":"2020","unstructured":"Khallaf RA, Aboud HM, Sayed OM. Surface modified niosomes of olanzapine for brain targeting via nasal route; preparation, optimization, and in vivo evaluation. J Liposome Res. 2020;30:163\u201373. https:\/\/doi.org\/10.1080\/08982104.2019.1610435.","journal-title":"J Liposome Res"},{"key":"2193_CR34","doi-asserted-by":"publisher","unstructured":"Mahajan S, Singh D, Sharma R, Singh G, Bedi N. pH-Independent Dissolution and Enhanced Oral Bioavailability of Aripiprazole-Loaded Solid Self-microemulsifying Drug Delivery System. AAPS PharmSciTech. 2021;22. https:\/\/doi.org\/10.1208\/s12249-020-01882-y.","DOI":"10.1208\/s12249-020-01882-y"},{"key":"2193_CR35","doi-asserted-by":"crossref","unstructured":"Al-Najjar A, Khalifa M., \u2026 O.A.-J. of D.D., undefined 2024, Epigallocatechin-3-gallate loaded proliposomal vesicles for management of traumatic brain injury: In-vitro and in-vivo evaluation, Elsevier (n.d.). (accessed June 13, 2025) https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1773224724004143","DOI":"10.1016\/j.jddst.2024.105745"},{"key":"2193_CR36","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.ijpharm.2018.11.005","volume":"554","author":"H McFall","year":"2019","unstructured":"McFall H, Sarabu S, Shankar V, Bandari S, Murthy SN, Kolter K, et al. Formulation of aripiprazole-loaded pH-modulated solid dispersions via hot-melt extrusion technology: In vitro and in vivo studies. Int J Pharm. 2019;554:302\u201311. https:\/\/doi.org\/10.1016\/j.ijpharm.2018.11.005.","journal-title":"Int J Pharm"},{"key":"2193_CR37","doi-asserted-by":"publisher","unstructured":"Maqsood S, Din FU, Khan SU, Elahi E, Ali Z, Jamshaid H, et al. Levosulpiride-loaded nanostructured lipid carriers for brain delivery with antipsychotic and antidepressant effects. Life Sci. 2022;311. https:\/\/doi.org\/10.1016\/j.lfs.2022.121198.","DOI":"10.1016\/j.lfs.2022.121198"},{"key":"2193_CR38","doi-asserted-by":"crossref","unstructured":"Shah B, Khunt D, Misra M. H.P.-I. journal of biological, undefined 2016, Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route*, Elsevier (n.d.). https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0141813016303841 (accessed March 29, 2023).","DOI":"10.1016\/j.ijbiomac.2016.04.076"},{"key":"2193_CR39","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1002\/BMC.2698","volume":"26","author":"F Liang","year":"2012","unstructured":"Liang F, Terry AV, Bartlett MG. Determination of aripiprazole in rat plasma and brain using ultra-performance liquid chromatography\/electrospray ionization tandem mass spectrometry. Biomed Chromatogr. 2012;26:1325\u201332. https:\/\/doi.org\/10.1002\/BMC.2698.","journal-title":"Biomed Chromatogr"},{"key":"2193_CR40","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.1080\/10717544.2016.1223216","volume":"23","author":"SA Nour","year":"2016","unstructured":"Nour SA, Abdelmalak NS, Naguib MJ, Rashed HM, Ibrahim AB. Intranasal brain-targeted clonazepam polymeric micelles for immediate control of status epilepticus: in vitro optimization, ex vivo determination of cytotoxicity, in vivo biodistribution and pharmacodynamics studies. Drug Deliv. 2016;23:3681\u201395. https:\/\/doi.org\/10.1080\/10717544.2016.1223216.","journal-title":"Drug Deliv"},{"key":"2193_CR41","doi-asserted-by":"crossref","unstructured":"Sayyed M, El-Motaleb MA. \u2026 I.I.-E.J. of, undefined 2022, Preparation, characterization,and in vivo biodistribution study of intranasal 131I-clonazepam-loaded phospholipid magnesome as a promising brain delivery, Elsevier (n.d.). (accessed November 11, 2023) https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0928098721003900","DOI":"10.1016\/j.ejps.2021.106089"},{"key":"2193_CR42","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/J.IJBIOMAC.2016.04.076","volume":"89","author":"B Shah","year":"2016","unstructured":"Shah B, Khunt D, Misra M, Padh H. Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route*. Int J Biol Macromol. 2016;89:206\u201318. https:\/\/doi.org\/10.1016\/J.IJBIOMAC.2016.04.076.","journal-title":"Int J Biol Macromol"},{"key":"2193_CR43","doi-asserted-by":"crossref","unstructured":"Teaima M, El-Nadi M, Hamed R. M.E.-N.- Pharmaceuticals, undefined 2023\u200f, Lyophilized Nasal Inserts of Atomoxetine HCl Solid Lipid Nanoparticles for Brain Targeting as a Treatment of Attention-Deficit\/Hyperactivity Disorder (ADHD)\u200f, Mdpi.Com\u200fMH Teaima, MT El-Nadi, RR Hamed, MA El-Nabarawi, R Abdelmonem\u200fPharmaceuticals, 2023\u200f\u2022mdpi.Com\u200f (n.d.) https:\/\/www.mdpi.com\/1424-8247\/16\/2\/326 (accessed October 28, 2023).","DOI":"10.3390\/ph16020326"},{"key":"2193_CR44","doi-asserted-by":"publisher","unstructured":"El Taweel MM, Aboul-Einien MH, Kassem MA, Elkasabgy NA, Kumar P, Cavalli R. Intranasal zolmitriptan-loaded bilosomes with extended nasal mucociliary transit time for direct nose to brain delivery\u200f, Mdpi.Com (2021). https:\/\/doi.org\/10.3390\/pharmaceutics13111828.","DOI":"10.3390\/pharmaceutics13111828"},{"key":"2193_CR45","doi-asserted-by":"publisher","unstructured":"Ibrahim TM, Eissa RG, El-Megrab NA, El-Nahas HM. Morphological characterization of optimized risperidone-loaded in-situ gel forming implants with pharmacokinetic and behavioral assessments in rats. J Drug Deliv Sci Technol. 2021;61. https:\/\/doi.org\/10.1016\/j.jddst.2020.102195.","DOI":"10.1016\/j.jddst.2020.102195"},{"key":"2193_CR46","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ijpharm.2014.10.006","volume":"477","author":"AM Avachat","year":"2014","unstructured":"Avachat AM, Kapure SS. Asenapine maleate in situ forming biodegradable implant: An approach to enhance bioavailability. Int J Pharm. 2014;477:64\u201372. https:\/\/doi.org\/10.1016\/j.ijpharm.2014.10.006.","journal-title":"Int J Pharm"},{"key":"2193_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-60761-303-9","volume":"42","author":"TD Gould","year":"2009","unstructured":"Gould TD, Dao DT, Kovacsics CE. Mood and Anxiety Related Phenotypes in Mice. Neuromethods. 2009;42:1\u201320. https:\/\/doi.org\/10.1007\/978-1-60761-303-9.","journal-title":"Neuromethods"},{"key":"2193_CR48","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1080\/10717544.2017.1377315","volume":"24","author":"M Yadav","year":"2017","unstructured":"Yadav M, Parle M, Sharma N, Dhingra S, Raina N, Jindal DK. Brain targeted oral delivery of doxycycline hydrochloride encapsulated tween 80 coated chitosan nanoparticles against ketamine induced psychosis: Behavioral, biochemical, neurochemical and histological alterations in mice. Drug Deliv. 2017;24:1429\u201340. https:\/\/doi.org\/10.1080\/10717544.2017.1377315.","journal-title":"Drug Deliv"},{"key":"2193_CR49","doi-asserted-by":"publisher","unstructured":"Khalil HMA, Mahmoud DB, El-Shiekh RA, Bakr AF, Boseila AA, Mehanna S, et al. Antidepressant and Cardioprotective Effects of Self-Nanoemulsifying Self-Nanosuspension Loaded with Hypericum perforatum on Post-Myocardial Infarction Depression in Rats. AAPS PharmSciTech. 2022;23. https:\/\/doi.org\/10.1208\/S12249-022-02387-6.","DOI":"10.1208\/S12249-022-02387-6"},{"key":"2193_CR50","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.22038\/IJBMS.2020.46469.10731","volume":"23","author":"HMM Badawi","year":"2020","unstructured":"Badawi HMM, Abdelsalam RM, Abdel-Salam OME, Youness ER, Shaffie NM, Eldenshary EEDS. Bee venom attenuates neurodegeneration and motor impairment and modulates the response to L-dopa or rasagiline in a mice model of Parkinson\u2019s disease. Iran J Basic Med Sci. 2020;23:1628. https:\/\/doi.org\/10.22038\/IJBMS.2020.46469.10731.","journal-title":"Iran J Basic Med Sci"},{"key":"2193_CR51","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1007\/S12035-014-8798-2\/FIGURES\/7","volume":"51","author":"ZQ Zhou","year":"2015","unstructured":"Zhou ZQ, Zhang GF, Li XM, Liu XY, Wang N, Qiu LL, et al. Loss of Phenotype of Parvalbumin Interneurons in Rat Prefrontal Cortex Is Involved in Antidepressant- and Propsychotic-Like Behaviors Following Acute and Repeated Ketamine Administration. Mol Neurobiol. 2015;51:808\u201319. https:\/\/doi.org\/10.1007\/S12035-014-8798-2\/FIGURES\/7.","journal-title":"Mol Neurobiol"},{"key":"2193_CR52","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1080\/10717544.2017.1377315","volume":"24","author":"M Yadav","year":"2017","unstructured":"Yadav M, Parle M, Sharma N, Dhingra S, Raina N, Jindal DK. Brain targeted oral delivery of doxycycline hydrochloride encapsulated Tween 80 coated chitosan nanoparticles against ketamine induced psychosis: behavioral. Drug Delivery. 2017;24:1429\u201340. https:\/\/doi.org\/10.1080\/10717544.2017.1377315","journal-title":"Drug Delivery"},{"key":"2193_CR53","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.3390\/BIOMEDICINES10071706","volume":"10","author":"R Boyuklieva","year":"2022","unstructured":"Boyuklieva R, Pilicheva B. Micro- and Nanosized Carriers for Nose-to-Brain Drug Delivery in Neurodegenerative Disorders. Biomedicines. 2022;10:1706. . https:\/\/doi.org\/10.3390\/BIOMEDICINES10071706","journal-title":"Biomedicines"},{"key":"2193_CR54","doi-asserted-by":"publisher","first-page":"7861","DOI":"10.2147\/IJN.S269004","volume":"15","author":"M Bin-Jumah","year":"2020","unstructured":"Bin-Jumah M, Gilani SJ, Jahangir MA, Zafar A, Alshehri S, Yasir M, et al. Clarithromycin-loaded ocular chitosan nanoparticle: Formulation, optimization, characterization, ocular irritation, and antimicrobial activity. Int J Nanomed. 2020;15:7861\u201375. https:\/\/doi.org\/10.2147\/IJN.S269004.","journal-title":"Int J Nanomed"},{"key":"2193_CR55","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/J.COLSURFB.2017.05.055","volume":"157","author":"N Sawtarie","year":"2017","unstructured":"Sawtarie N, Cai Y, Lapitsky Y. Preparation of chitosan\/tripolyphosphate nanoparticles with highly tunable size and low polydispersity. Colloids Surf B Biointerfaces. 2017;157:110\u20137. https:\/\/doi.org\/10.1016\/J.COLSURFB.2017.05.055.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"2193_CR56","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/PHARMACEUTICS10020057","volume":"10","author":"M Danaei","year":"2018","unstructured":"Danaei M, Dehghankhold M, Ataei S, Hasanzadeh Davarani F, Javanmard R, Dokhani A, et al. Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems. Pharmaceutics. 2018;10:57. https:\/\/doi.org\/10.3390\/PHARMACEUTICS10020057","journal-title":"Pharmaceutics"},{"key":"2193_CR57","doi-asserted-by":"publisher","first-page":"618","DOI":"10.3390\/NANO12040618","volume":"12","author":"A Kushwaha","year":"2022","unstructured":"Kushwaha A, Goswami L, Kim BS. Nanomaterial-Based Therapy for Wound Healing, Nanomaterials. 2022;12:618. https:\/\/doi.org\/10.3390\/NANO12040618","journal-title":"Nanomaterials"},{"key":"2193_CR58","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/J.IJBIOMAC.2017.11.170","volume":"108","author":"Ameeduzzafar","year":"2018","unstructured":"Ameeduzzafar, Imam SS, Abbas Bukhari SN, Ahmad J, Ali A. Formulation and optimization of levofloxacin loaded chitosan nanoparticle for ocular delivery: In-vitro characterization, ocular tolerance and antibacterial activity. Int J Biol Macromol. 2018;108:650\u20139. https:\/\/doi.org\/10.1016\/J.IJBIOMAC.2017.11.170.","journal-title":"Int J Biol Macromol"},{"key":"2193_CR59","doi-asserted-by":"publisher","first-page":"e413","DOI":"10.5301\/JABFM.5000278\/ASSET\/IMAGES\/LARGE\/10.5301_JABFM.5000278-FIG5.JPEG","volume":"14","author":"N Kiaie","year":"2016","unstructured":"Kiaie N, Aghdam RM, Tafti SHA, Emami SH. Statistical optimization of chitosan nanoparticles as protein vehicles, using response surface methodology. J Appl Biomater Funct Mater. 2016;14:e413\u201322. https:\/\/doi.org\/10.5301\/JABFM.5000278\/ASSET\/IMAGES\/LARGE\/10.5301_JABFM.5000278-FIG5.JPEG.","journal-title":"J Appl Biomater Funct Mater"},{"key":"2193_CR60","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/J.IJPHARM.2018.06.031","volume":"547","author":"J Fernandes","year":"2018","unstructured":"Fernandes J, Ghate MV, Basu Mallik S, Lewis SA. Amino acid conjugated chitosan nanoparticles for the brain targeting of a model dipeptidyl peptidase-4 inhibitor. Int J Pharm. 2018;547:563\u201371. https:\/\/doi.org\/10.1016\/J.IJPHARM.2018.06.031.","journal-title":"Int J Pharm"},{"key":"2193_CR61","doi-asserted-by":"publisher","first-page":"4421","DOI":"10.3390\/MOLECULES29184421","volume":"29","author":"A de Amaury Bautista Solano","year":"2024","unstructured":"Amaury Bautista Solano A, D\u00e1vila-Ortiz G, de Jes\u00fas Perea-Flores M, Leticia Mart\u00ednez-Ayala A, Stampa M, Gustavo Madero AA, et al. Optimization and Synthesis of Nano-Niosomes for Encapsulation of Triacontanol by Box\u2013Behnken Design. Molecules. 2024;29:4421. https:\/\/doi.org\/10.3390\/MOLECULES29184421","journal-title":"Molecules"},{"key":"2193_CR62","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.cclet.2015.05.044","volume":"26","author":"YZ Chen","year":"2015","unstructured":"Chen YZ, Huang YK, Chen Y, Ye YJ, Lou KY, Gao F. Novel nanoparticles composed of chitosan and \u03b2-cyclodextrin derivatives as potential insoluble drug carrier. Chin Chem Lett. 2015;26:909\u201313. https:\/\/doi.org\/10.1016\/j.cclet.2015.05.044.","journal-title":"Chin Chem Lett"},{"key":"2193_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/ph15030370","author":"MZ Ahmad","year":"2022","unstructured":"Ahmad MZ, Sabri AHB, Ahmad MZ, Hidyat A, Sabri B, Kurnia Anjani Q, et al. Design and development of levodopa loaded polymeric nanoparticles for intranasal delivery. Mdpi Com. 2022. https:\/\/doi.org\/10.3390\/ph15030370.","journal-title":"Mdpi Com"},{"key":"2193_CR64","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/J.COLSURFA.2015.04.006","volume":"482","author":"S Hassani","year":"2015","unstructured":"Hassani S, Laouini A, Fessi H, Charcosset C. Preparation of chitosan\u2013TPP nanoparticles using microengineered membranes \u2013 Effect of parameters and encapsulation of tacrine, Colloids Surf. Physicochem Eng Asp. 2015;482:34\u201343. https:\/\/doi.org\/10.1016\/J.COLSURFA.2015.04.006.","journal-title":"Physicochem Eng Asp"},{"key":"2193_CR65","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/J.EJPS.2012.04.013","volume":"47","author":"M Fazil","year":"2012","unstructured":"Fazil M, Md S, Haque S, Kumar M, Baboota S, Sahni JK, et al. Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting. Eur J Pharm Sci. 2012;47:6\u201315. https:\/\/doi.org\/10.1016\/J.EJPS.2012.04.013.","journal-title":"Eur J Pharm Sci"},{"key":"2193_CR66","doi-asserted-by":"crossref","unstructured":"M. Badie, M. Teaima, \u2026 M.E.-N.-I.J. of, undefined 2024, Formulation and optimization of surfactant-modified chitosan nanoparticles loaded with cefdinir for novel topical drug delivery: Elevating wound healing efficacy with enhanced antibacterial properties, International Journal of Pharmaceutics, 2024\u2022Elsevier (n.d.). https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0378517324009979 (accessed July 11, 2025).","DOI":"10.1016\/j.ijpharm.2024.124763"},{"key":"2193_CR67","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1016\/J.IJBIOMAC.2020.10.182","volume":"165","author":"B Hou","year":"2020","unstructured":"Hou B, Qi M, Sun J, Ai M, Ma X, Cai W, et al. Preparation, characterization and wound healing effect of vaccarin-chitosan nanoparticles. Int J Biol Macromol. 2020;165:3169\u201379. https:\/\/doi.org\/10.1016\/J.IJBIOMAC.2020.10.182.","journal-title":"Int J Biol Macromol"},{"key":"2193_CR68","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1080\/03639045.2019.1619759","volume":"45","author":"R Rukmangathen","year":"2019","unstructured":"Rukmangathen R, Yallamalli IM, Yalavarthi PR. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery. Drug Dev Ind Pharm. 2019;45:1342\u201350. https:\/\/doi.org\/10.1080\/03639045.2019.1619759.","journal-title":"Drug Dev Ind Pharm"},{"key":"2193_CR69","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/J.IJBIOMAC.2015.08.035","volume":"81","author":"GP Hansraj","year":"2015","unstructured":"Hansraj GP, Singh SK, Kumar P. Sumatriptan succinate loaded chitosan solid lipid nanoparticles for enhanced anti-migraine potential. Int J Biol Macromol. 2015;81:467\u201376. https:\/\/doi.org\/10.1016\/J.IJBIOMAC.2015.08.035.","journal-title":"Int J Biol Macromol"},{"key":"2193_CR70","doi-asserted-by":"publisher","unstructured":"Furtado D, Bj\u00f6rnmalm M, Ayton S, Bush AI, Kempe K, Caruso F, et al. Overcoming the blood\u2013brain barrier: the role of nanomaterials in treating neurological diseases. Wiley Online Libr. 2018;30. https:\/\/doi.org\/10.1002\/adma.201801362.","DOI":"10.1002\/adma.201801362"},{"key":"2193_CR71","doi-asserted-by":"publisher","unstructured":"Baltzley S, Mohammad A, Malkawi AH, Al-Ghananeem AM. Intranasal drug delivery of olanzapine-loaded chitosan nanoparticles, SpringerS Baltzley, A Mohammad, AH Malkawi, AM Al-GhananeemAAPS PharmSciTech, 2014\u2022Springer 15 (2014) 1598\u20131602. https:\/\/doi.org\/10.1208\/S12249-014-0189-5","DOI":"10.1208\/S12249-014-0189-5"},{"key":"2193_CR72","doi-asserted-by":"publisher","first-page":"886","DOI":"10.3390\/PH16060886\/S1","volume":"16","author":"HA Abo El-Enin","year":"2023","unstructured":"Abo El-Enin HA, Tulbah AS, Darwish HW, Salama R, Naguib IA, Yassin HA. Abdel-Bar, Evaluation of Brain Targeting and Antipsychotic Activity of Nasally Administrated Ziprasidone Lipid\u2013Polymer Hybrid Nanocarriers. Pharmaceuticals. 2023;16:886. https:\/\/doi.org\/10.3390\/PH16060886\/S1.","journal-title":"Pharmaceuticals"},{"key":"2193_CR73","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1080\/03639045.2016.1236808","volume":"43","author":"JA Kulkarni","year":"2017","unstructured":"Kulkarni JA, Avachat AM. Pharmacodynamic and pharmacokinetic investigation of cyclodextrin-mediated asenapine maleate in situ nasal gel for improved bioavailability. Drug Dev Ind Pharm. 2017;43:234\u201345. https:\/\/doi.org\/10.1080\/03639045.2016.1236808.","journal-title":"Drug Dev Ind Pharm"},{"key":"2193_CR74","doi-asserted-by":"crossref","unstructured":"Farkhakfar A, Hassanpour S, Letters MZ-N. undefined 2023, Resveratrol plays neuroprotective role on ketamine-induced schizophrenia-like behaviors and oxidative damage in mice, Elsevier (n.d.). https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0304394023003956 (accessed September 24, 2023).","DOI":"10.1016\/j.neulet.2023.137436"},{"key":"2193_CR75","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/S10787-017-0366-8\/FIGURES\/1","volume":"26","author":"M Yadav","year":"2018","unstructured":"Yadav M, Jindal DK, Dhingra MS, Kumar A, Parle M, Dhingra S. Protective effect of gallic acid in experimental model of ketamine-induced psychosis: possible behaviour, biochemical, neurochemical and cellular alterations. Inflammopharmacology. 2018;26:413\u201324. https:\/\/doi.org\/10.1007\/S10787-017-0366-8\/FIGURES\/1.","journal-title":"Inflammopharmacology"},{"key":"2193_CR76","doi-asserted-by":"publisher","unstructured":"Sikander M, Tulain UR, Malik NS, Mahmood A, Erum A, Khan MT, Safdar A. In Vitro\/In Vivo Assessment of Aripiprazole-Loaded Thiolated Arabinoxylan based Nanoparticles: An Innovative Approach for Targeted Schizophrenia Therapy, BioRxiv (2024) 2024.02.13.580125. https:\/\/doi.org\/10.1101\/2024.02.13.580125","DOI":"10.1101\/2024.02.13.580125"},{"key":"2193_CR77","doi-asserted-by":"publisher","unstructured":"J. Eduardo Su\u00e1rez Santiago, S. Orozco-Su\u00e1rez, A. Vega Garcia, O. Picazo, Repeated ketamine administration induces recognition memory impairment together with morphological changes in neurons from ventromedial prefrontal cortex, Ingentaconnect.Com. Behavioural Pharmacology, 2020\u2022ingentaconnect.Com (2020). https:\/\/doi.org\/10.1097\/FBP.0000000000000571","DOI":"10.1097\/FBP.0000000000000571"},{"key":"2193_CR78","doi-asserted-by":"crossref","unstructured":"S. Perrine, F. Ghoddoussi, \u2026 M.M.-P. in N., undefined 2014, Ketamine reverses stress-induced depression-like behavior and increased GABA levels in the anterior cingulate: an 11.7 T 1H-MRS study in rats, Elsevier (n.d.). https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0278584613002467 (accessed November 23, 2023).","DOI":"10.1016\/j.pnpbp.2013.11.003"},{"key":"2193_CR79","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1007\/S10787-022-01031-W\/FIGURES\/2","volume":"30","author":"DA Nawwar","year":"2022","unstructured":"Nawwar DA, Zaki HF, Sayed RH. Role of the NRG1\/ErbB4 and PI3K\/AKT\/mTOR signaling pathways in the anti-psychotic effects of aripiprazole and sertindole in ketamine-induced schizophrenia-like behaviors in rats. Inflammopharmacology. 2022;30:1891\u2013907. https:\/\/doi.org\/10.1007\/S10787-022-01031-W\/FIGURES\/2.","journal-title":"Inflammopharmacology"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02193-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-026-02193-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02193-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T16:23:15Z","timestamp":1786206195000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-026-02193-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,8]]},"references-count":78,"alternative-id":["2193"],"URL":"https:\/\/doi.org\/10.1007\/s13346-026-02193-8","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,8]]},"assertion":[{"value":"5 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the ethical committee, Faculty of Pharmacy, Cairo University, approval no. 2900, and was performed following the guidelines for the Care and Use of Laboratory Animals.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}